{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:05:33Z","timestamp":1793127933315,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jfma.2025.01.008","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T08:27:34Z","timestamp":1736929654000},"page":"S55-S62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S1","title":["Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9707-1929","authenticated-orcid":false,"given":"Cheng-Hsuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5204-154X","authenticated-orcid":false,"given":"Sung-Ju","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Kai","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2224-4140","authenticated-orcid":false,"given":"Shao-Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3885-6600","authenticated-orcid":false,"given":"Hao-Min","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0678-2264","authenticated-orcid":false,"given":"Chih-Fan","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4721-1468","authenticated-orcid":false,"given":"Hsin-Hsi","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2025.01.008_bib1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/CIRCRESAHA.118.313236","article-title":"Hypertension management in older and frail older patients","volume":"124","author":"Benetos","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jfma.2025.01.008_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jfma.2025.01.008_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jnnp.74.3.317","article-title":"Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study","volume":"74","author":"Hollander","year":"2003","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.jfma.2025.01.008_bib4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","article-title":"Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study","volume":"388","author":"O'Donnell","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2025.01.008_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.313.7050.147","article-title":"Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group","volume":"313","author":"Rodgers","year":"1996","journal-title":"Bmj"},{"key":"10.1016\/j.jfma.2025.01.008_bib6","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.STR.0000126208.14181.DD","article-title":"Blood pressure and stroke: an overview of published reviews","volume":"35","author":"Lawes","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jfma.2025.01.008_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2025.01.008_bib8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jamaneurol.2023.0218","article-title":"Association between magnitude of differential blood pressure reduction and secondary stroke prevention: a meta-analysis and meta-regression","volume":"80","author":"Hsu","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jfma.2025.01.008_bib9","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2025.01.008_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2025.01.008_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.284.4.465","article-title":"Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of StrokeThe systolic hypertension in the elderly program (SHEP)","volume":"284","author":"Perry","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2025.01.008_bib12","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 Years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2025.01.008_bib13","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged >\/=75 Years: a randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2025.01.008_bib14","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2025.01.008_bib15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/jgs.14712","article-title":"Outcomes of treated hypertension at age 80 and older: cohort analysis of 79,376 individuals","volume":"65","author":"Delgado","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jfma.2025.01.008_bib16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jamainternmed.2014.8012","article-title":"Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study","volume":"175","author":"Benetos","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jfma.2025.01.008_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/ageing\/afy072","article-title":"Lower blood pressure during antihypertensive treatment is associated with higher all-cause mortality and accelerated cognitive decline in the oldest-old. Data from the Leiden 85-plus Study","volume":"47","author":"Streit","year":"2018","journal-title":"Age Ageing"},{"key":"10.1016\/j.jfma.2025.01.008_bib18","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/hr.2009.139","article-title":"Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature","volume":"32","author":"Liu","year":"2009","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jfma.2025.01.008_bib19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"Group","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2025.01.008_bib20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00004872-200403000-00030","article-title":"Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region","volume":"22","author":"Rodgers","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2025.01.008_bib21","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2025.01.008_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022240","article-title":"Is blood pressure lowering in the very elderly with previous stroke associated with a higher risk of adverse events?","volume":"10","author":"Tharmaratnam","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jfma.2025.01.008_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2025.01.008_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jfma.2025.01.008_bib25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/jgs.13349","article-title":"Can blood pressure be lowered safely in older adults with lacunar stroke? The Secondary Prevention of Small Subcortical Strokes study experience","volume":"63","author":"White","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jfma.2025.01.008_bib26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","article-title":"Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis","volume":"76","author":"Kitagawa","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jfma.2025.01.008_bib27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41440-022-00862-y","article-title":"Intensive or standard blood pressure control in patients with a history of ischemic stroke: RESPECT post hoc analysis","volume":"45","author":"Kitagawa","year":"2022","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jfma.2025.01.008_bib97","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/01.STR.24.4.543","article-title":"Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group","volume":"24","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jfma.2025.01.008_bib98","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000107813","article-title":"Atenolol in secondary prevention after stroke","volume":"5","author":"Eriksson","year":"1995","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jfma.2025.01.008_bib99","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.STR.0000166048.35740.a9","article-title":"Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES)","volume":"36","author":"Schrader","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jfma.2025.01.008_bib100","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2025.01.008_bib101","article-title":"Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention after Stroke--Blood Pressure) randomised controlled trial","volume":"352","author":"Mant","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jfma.2025.01.008_bib28","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","article-title":"Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2025.01.008_bib29","article-title":"Comparative effectiveness of blood pressure-lowering drugs in patients who have already suffered from stroke: traditional and bayesian network meta-analysis of randomized trials","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jfma.2025.01.008_bib30","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/HJH.0000000000001720","article-title":"Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis","volume":"36","author":"Xie","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2025.01.008_bib31","article-title":"Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack","volume":"7","author":"Zonneveld","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfma.2025.01.008_bib32","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart association\/American stroke association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jfma.2025.01.008_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5853\/jos.2020.02698","article-title":"Role of blood pressure management in stroke prevention: a systematic review and network meta-analysis of 93 randomized controlled trials","volume":"23","author":"Zhong","year":"2021","journal-title":"J Stroke"},{"key":"10.1016\/j.jfma.2025.01.008_bib34","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/JCMA.0000000000000738","article-title":"Taiwan Stroke Society Guidelines of blood pressure control for ischemic stroke prevention","volume":"85","author":"Chi","year":"2021","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.jfma.2025.01.008_bib35","first-page":"225","article-title":"2022 guidelines of the taiwan society of Cardiology and the taiwan hypertension society for the management of hypertension","volume":"38","author":"Wang","year":"2022","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.jfma.2025.01.008_bib36","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","article-title":"Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart association\/American stroke association","volume":"53","author":"Greenberg","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.jfma.2025.01.008_bib37","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2025.01.008_bib38","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1161\/01.STR.0000094424.38761.56","article-title":"Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease","volume":"34","author":"Rothwell","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jfma.2025.01.008_bib39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.09.044","article-title":"Higher stroke risk with lower blood pressure in hemodynamic vertebrobasilar disease: analysis from the VERiTAS study","volume":"26","author":"Amin-Hanjani","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jfma.2025.01.008_bib40","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1097\/HJH.0000000000001784","article-title":"Intensive blood pressure control may not be safe in subacute ischemic stroke by intracranial atherosclerosis: a result of randomized trial","volume":"36","author":"Park","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2025.01.008_bib41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.2019.10575","article-title":"Association of midlife to late-life blood pressure patterns with incident dementia","volume":"322","author":"Walker","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2025.01.008_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.120.14993","article-title":"Blood pressure and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 209 prospective studies","volume":"76","author":"Ou","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2025.01.008_bib43","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/HYPERTENSIONAHA.121.17608","article-title":"The association of age at diagnosis of hypertension with brain structure and incident dementia in the UK biobank","volume":"78","author":"Shang","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2025.01.008_bib44","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2025.01.008_bib45","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis","volume":"323","author":"Hughes","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2025.01.008_bib46","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.amjhyper.2005.02.013","article-title":"Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: study on COgnition and Prognosis in the Elderly (SCOPE)","volume":"18","author":"Skoog","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jfma.2025.01.008_bib47","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/jhh.2013.107","article-title":"The evidence for treating hypertension in older people with dementia: a systematic review","volume":"28","author":"Beishon","year":"2014","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jfma.2025.01.008_bib48","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jamda.2019.03.036","article-title":"Treatment of hypertension in people with dementia: a multicenter prospective observational cohort study","volume":"20","author":"Welsh","year":"2019","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jfma.2025.01.008_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2318-14-19","article-title":"The treatment of hypertension in people with dementia: a systematic review of observational studies","volume":"14","author":"Welsh","year":"2014","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jfma.2025.01.008_bib50","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2025.01.008_bib51","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2025.01.008_bib52","first-page":"3255","article-title":"Final results of the systolic hypertension in the elderly program (SHEP). SHEP cooperative research group","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2025.01.008_bib53","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209715","article-title":"Blood pressure, antihypertensive use, and late-life alzheimer and non-alzheimer dementia risk: an individual participant data meta-analysis","volume":"103","author":"Lennon","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.jfma.2025.01.008_bib54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trsl.2020.01.002","article-title":"Frailty and cognitive decline","volume":"221","author":"Fabricio","year":"2020","journal-title":"Transl Res"},{"key":"10.1016\/j.jfma.2025.01.008_bib55","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/jgs.15421","article-title":"Hypotensive drugs and syncope due to orthostatic hypotension in older adults with dementia (syncope and dementia study)","volume":"66","author":"Testa","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jfma.2025.01.008_bib56","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.STR.0000155686.73908.3e","article-title":"Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial","volume":"36","author":"Pantoni","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jfma.2025.01.008_bib57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0022-510X(00)00301-4","article-title":"The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia","volume":"175","author":"Pantoni","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jfma.2025.01.008_bib58","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3233\/JAD-2012-121090","article-title":"Associations of angiotensin targeting antihypertensive drugs with mortality and hospitalization in primary care patients with dementia","volume":"33","author":"Kehoe","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jfma.2025.01.008_bib59","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/jgs.14225","article-title":"Etiology of syncope and unexplained falls in elderly adults with dementia: syncope and dementia (SYD) study","volume":"64","author":"Ungar","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jfma.2025.01.008_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.06.001","article-title":"A comparison of the prevalence of orthostatic hypotension between older patients with Alzheimer's Disease, Lewy body dementia, and without dementia","volume":"124","author":"Isik","year":"2019","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jfma.2025.01.008_bib61","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/gps.1861","article-title":"The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies","volume":"23","author":"Andersson","year":"2008","journal-title":"Int J Geriatr Psychiatr"},{"key":"10.1016\/j.jfma.2025.01.008_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1221069","article-title":"Global prevalence of polypharmacy and potentially inappropriate medication in older patients with dementia: a systematic review and meta-analysis","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jfma.2025.01.008_bib63","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1532-5415.2001.4930277.x","article-title":"The appropriateness of drug use in an older nondemented and demented population","volume":"49","author":"Giron","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jfma.2025.01.008_bib64","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00228-013-1506-8","article-title":"Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs","volume":"69","author":"Montastruc","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jfma.2025.01.008_bib65","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1099-1166(200003)15:3<242::AID-GPS110>3.0.CO;2-7","article-title":"Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications","volume":"15","author":"Grossberg","year":"2000","journal-title":"Int J Geriatr Psychiatr"},{"key":"10.1016\/j.jfma.2025.01.008_bib66","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2165\/00002018-200730110-00005","article-title":"Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary)","volume":"30","author":"Tavassoli","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.jfma.2025.01.008_bib67","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/106002809502900610","article-title":"Interactions between antipsychotic and antihypertensive drugs","volume":"29","author":"Markowitz","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jfma.2025.01.008_bib68","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup","year":"2018","journal-title":"World Psychiatr"},{"key":"10.1016\/j.jfma.2025.01.008_bib69","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jfma.2025.01.008_bib70","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2025.01.008_bib71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000496977","article-title":"Association between hypertension and the risk of Parkinson's disease: a meta-analysis of analytical studies","volume":"52","author":"Chen","year":"2019","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jfma.2025.01.008_bib72","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/HYPERTENSIONAHA.111.171249","article-title":"Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study","volume":"57","author":"Qiu","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2025.01.008_bib73","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41531-021-00202-w","article-title":"Case-control study of hypertension and Parkinson's disease","volume":"7","author":"Ng","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.jfma.2025.01.008_bib74","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000054770","article-title":"Risk factors for Parkinson's disease: the leisure world cohort study","volume":"20","author":"Paganini-Hill","year":"2001","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jfma.2025.01.008_bib75","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1212\/01.wnl.0000303818.38960.44","article-title":"Use of antihypertensives and the risk of Parkinson disease","volume":"70","author":"Becker","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jfma.2025.01.008_bib76","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.parkreldis.2005.09.004","article-title":"Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk","volume":"12","author":"Powers","year":"2006","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.jfma.2025.01.008_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/JPD-191763","article-title":"Ethnic variation in the manifestation of Parkinson's disease: a narrative review","volume":"10","author":"Ben-Joseph","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jfma.2025.01.008_bib78","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/mdc3.12454","article-title":"Autonomic dysfunction in early Parkinson's disease: results from the United Kingdom tracking Parkinson's study","volume":"4","author":"Malek","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.jfma.2025.01.008_bib79","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41440-022-01032-w","article-title":"Abnormal circadian blood pressure regulation and cognitive impairment in alpha-synucleinopathies","volume":"45","author":"Tanaka","year":"2022","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jfma.2025.01.008_bib80","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.parkreldis.2016.09.013","article-title":"Orthostatic hypotension in Parkinson's disease: does it matter if asymptomatic?","volume":"33","author":"Merola","year":"2016","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.jfma.2025.01.008_bib81","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/mds.22767","article-title":"Loss of nocturnal blood pressure fall in various extrapyramidal syndromes","volume":"24","author":"Schmidt","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.jfma.2025.01.008_bib82","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.3233\/JPD-202036","article-title":"Management of orthostatic hypotension in Parkinson's disease","volume":"10","author":"Fanciulli","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jfma.2025.01.008_bib83","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/pn-2020-002797","article-title":"Multiple system atrophy","volume":"23","author":"Goh","year":"2023","journal-title":"Practical Neurol"},{"key":"10.1016\/j.jfma.2025.01.008_bib84","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1097\/HJH.0000000000002536","article-title":"Characteristics of the 24-h ambulatory blood pressure monitoring in patients with Parkinson's disease - the SFC BP multicentre study in China","volume":"38","author":"Chen","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2025.01.008_bib85","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/HJH.0000000000002249","article-title":"Cardiac organ damage in patients with Parkinson's disease and reverse dipping","volume":"38","author":"Di Stefano","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2025.01.008_bib86","first-page":"e998","article-title":"Association between orthostatic hypotension and dementia in patients with Parkinson disease and multiple system atrophy","volume":"100","author":"Ruiz","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jfma.2025.01.008_bib87","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/00207454.2012.642038","article-title":"Differences in motor and cognitive function in patients with Parkinson's disease with and without orthostatic hypotension","volume":"122","author":"Hohler","year":"2012","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jfma.2025.01.008_bib88","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1097\/HJH.0000000000002505","article-title":"Blood pressure lability is associated with subcortical atrophy in early Parkinson's disease","volume":"38","author":"Yoo","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2025.01.008_bib89","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jamaneurol.2017.1125","article-title":"Association of autonomic dysfunction with disease progression and survival in Parkinson disease","volume":"74","author":"De Pablo-Fernandez","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jfma.2025.01.008_bib90","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.parkreldis.2014.04.007","article-title":"Cardiovascular effects of levodopa in Parkinson's disease","volume":"20","author":"Noack","year":"2014","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.jfma.2025.01.008_bib91","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/1531-8257(199903)14:2<246::AID-MDS1008>3.0.CO;2-P","article-title":"Selegiline-induced postural hypotension in Parkinson's disease: a longitudinal study on the effects of drug withdrawal","volume":"14","author":"Churchyard","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.jfma.2025.01.008_bib92","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/thoraxjnl-2011-201275","article-title":"Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications","volume":"68","author":"Singh","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jfma.2025.01.008_bib93","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1474-4422(19)30400-4","article-title":"beta-adrenoreceptors and the risk of Parkinson's disease","volume":"19","author":"Hopfner","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jfma.2025.01.008_bib94","article-title":"Beta2-adrenoreceptor agonists and long-term risk of Parkinson's disease","volume":"110","author":"Tuominen","year":"2023","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.jfma.2025.01.008_bib95","article-title":"Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2025.01.008_bib96","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207899","article-title":"Association between use of any of the drugs prescribed in Norway and the subsequent risk of Parkinson disease: a drug-wide association study","author":"Romanowska","year":"2023","journal-title":"Neurology"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T06:14:40Z","timestamp":1752732880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":101,"alternative-id":["S0929664625000087"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.01.008","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}